These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6960319)

  • 21. Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies.
    Bocci G; Man S; Green SK; Francia G; Ebos JM; du Manoir JM; Weinerman A; Emmenegger U; Ma L; Thorpe P; Davidoff A; Huber J; Hicklin DJ; Kerbel RS
    Cancer Res; 2004 Sep; 64(18):6616-25. PubMed ID: 15374976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel human monoclonal antibody derived from tumor-infiltrating lymphocytes in lung cancer inhibits cancer cell growth with morphological changes.
    Aoki M; Saikawa Y; Hosokawa S; Fukuda K; Kumai K; Kubota T; Yoshida M; Otani Y; Kitajima M
    Anticancer Res; 2005; 25(6B):3791-8. PubMed ID: 16309165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
    Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
    J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody OKT-9 recognizes the receptor for transferrin on human acute lymphocytic leukemia cells.
    Goding JW; Burns GF
    J Immunol; 1981 Sep; 127(3):1256-8. PubMed ID: 6790617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR; Taylor PA; Vallera DA
    J Immunol; 1994 Apr; 152(7):3665-74. PubMed ID: 8144942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
    Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
    J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new murine cell surface differentiation antigen (Leugp90) defined by a rat monoclonal antibody: cellular distribution and biochemical characterization.
    Moldenhauer G; Haustein D; Hüppe T; Wagner A; Hartmann KU
    J Immunol; 1982 Jun; 128(6):2664-9. PubMed ID: 6978911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial studies of numbers of circulating T and B lymphocytes in children with acute lymphoblastic leukaemia.
    Reid MM; Craft AW; Todd JA
    Arch Dis Child; 1977 Mar; 52(3):245-7. PubMed ID: 300613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia.
    Foon KA; Schroff RW; Bunn PA; Mayer D; Abrams PG; Fer M; Ochs J; Bottino GC; Sherwin SA; Carlo DJ
    Blood; 1984 Nov; 64(5):1085-93. PubMed ID: 6333257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice.
    Flavell DJ; Warnes SL; Noss AL; Flavell SU
    Br J Cancer; 2000 Dec; 83(12):1755-61. PubMed ID: 11104577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Leukapheresis for the initial treatment of acute lymphoblastic leukemia in childhood].
    Schöntube M; Dörffel W; Blauärmel O
    Padiatr Grenzgeb; 1983; 22(2-3):181-9. PubMed ID: 6577400
    [No Abstract]   [Full Text] [Related]  

  • 33. Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma.
    Ritz J; Schlossman SF
    Blood; 1982 Jan; 59(1):1-11. PubMed ID: 7032624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunologic phenotypes of acute lymphoblastic leukemias and their clinico-biological correlations].
    San Miguel JF; González M; Caballero MD; Moro MJ; Prieto M; Moraleda JM; Tamagnini G; López Borrasca A
    Sangre (Barc); 1984; 29(5):849-60. PubMed ID: 6596755
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical applications of monoclonal antibodies in acute leukemia.
    Ritz J; Bast RC; Takvorian T; Sallan SE
    Ann N Y Acad Sci; 1984; 428():308-17. PubMed ID: 6234835
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosis with monoclonal antibodies of "T acute lymphoblastic leukaemia" expressing an unusual phenotype.
    Gobbi M; Lauria F; Raspadori D; Bandini G; Tura S
    Haematologica; 1982 Jun; 67(3):487-8. PubMed ID: 6815008
    [No Abstract]   [Full Text] [Related]  

  • 37. [Demonstration of the efficacy of active immunotherapy in human acute lymphoblastic leukemia].
    Mathé G; Amiel JL; Schwarzenberg L; Schneider M; Cattan A; Schlumberger JR; Hayat M; de Vassal F
    Rev Fr Etud Clin Biol; 1968 May; 13(5):454-9. PubMed ID: 5244759
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of monoclonal antibodies to identify cerebrospinal fluid lymphoblasts in children with acute lymphoblastic leukemia.
    Homans AC; Forman EN; Barker BE
    Blood; 1985 Dec; 66(6):1321-5. PubMed ID: 3864496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acute lymphoblastic leukemia of thymic origin (Thy-ALL). Case report].
    Koubek K; Starý J; Malasková V; Hrodek O; Chudomel V; Goetz P; Komrska V
    Cesk Pediatr; 1984 Aug; 39(8):464-7. PubMed ID: 6333930
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lymphopenia caused by antilymphocyte serum in chronic lymphatic leukemia].
    Pfisterer H; Michlmayr G; Meinzel E; Bolland H; Tsirimbas AD; Hornung B; Ruppelt W; Stich W
    Dtsch Med Wochenschr; 1968 Nov; 93(45):2159-61. PubMed ID: 5683957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.